X0306 4 2021-08-02 0001613103 Medtronic plc MDT 0001559405 Lerman Bradley E 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 SVP General Counsel & Corp Sec Ordinary Shares 2021-08-02 4 S 0 4000 131.52 D 48194 D Ordinary Shares 2021-08-02 4 F 0 5450 131.31 D 42744 D Ordinary Shares 2021-08-02 4 A 0 6019 0 A 48763 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 51423 0 A 2022-08-02 2031-08-02 Ordinary Shares 51423 51423 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 1085 0 A 2022-08-02 2031-08-02 Ordinary Shares 1085 1085 D Performance Share Units 2021-08-02 4 A 0 15047 0 A Performance Share Units 15047 15047 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. This balance increased by 651 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,047 shares will be issued. The actual number of shares to be issued could range from a low of 3,010 at minimum performance to a high of 30,094 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on August 2, 2024. /s/ Thomas L. Osteraas, attorney-in-fact 2021-08-04